While there are limitations, the promise of improved diabetes management, cardiovascular benefits, and new formulations places GLP-1 agonists at the forefront of diabetes care
Results showed that at week 24, the 1mg group achieved an average weight loss of 7.2%, the 4mg combination group lost 12.9%, the 8mg combination group lost 17.3%, and the 12mg group lost 17.5%, while the placebo group lost only 1.6%
Its critical to make real lifestyle changes regardless of if you choose a medical weight loss program or take another path
Professional liability considerations may differ from those associated with FDA-approved medications, and providers should maintain comprehensive documentation of treatment rationale and patient consent
Vitamin B6 is added to semaglutide to possibly reduce gastrointestinal side effects, which may make it less likely for patients to skip doses or discontinue treatment